Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Alzheimer's
Alzheimer's
Page 5 of 8
Health
Biogen makes a drastic move, as doctors refuse to prescribe its controversial Alzheimer’s drug
By
Sy Mukherjee
July 8, 2021
Health
Biogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By
Sy Mukherjee
June 9, 2021
Health
FDA approves Biogen’s controversial Alzheimer’s drug in historic decision
By
Sy Mukherjee
June 7, 2021
Health
President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals
By
Sy Mukherjee
May 25, 2021
Newsletters
A week about Alzheimer’s drug development
By
Sy Mukherjee
March 18, 2021
Newsletters
Biogen is doubling down on Alzheimer’s with a massive gene therapy deal
By
Sy Mukherjee
February 28, 2020
Newsletters
The Broader Implications of Biogen’s Divisive Alzheimer’s Drug
By
Sy Mukherjee
December 5, 2019
Newsletters
Biogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet
By
Sy Mukherjee
December 2, 2019
Newsletters
Bill Gates Commits $10 Million More for Alzheimer’s Research to ‘Part the Cloud’
By
Sy Mukherjee
November 5, 2019
Newsletters
Let’s Talk About Biogen’s Stunning Alzheimer’s Drug Reversal: Brainstorm Health
By
Sy Mukherjee
October 23, 2019
Health
Roche Reports Another Failure in Big Pharma’s Search for Alzheimer’s Treatment
By
Lucas Laursen
January 30, 2019
Health
A New Blood Test Could Detect Alzheimers 10 Years Earlier
By
Emily Price
January 21, 2019
Magazine
The Power of a Joint Venture
By
Clifton Leaf
January 18, 2019
Could This Radical New Approach to Alzheimer’s Lead to a Breakthrough?
By
Rick Tetzeli
January 18, 2019
Magazine
Alzheimer’s: A Trail of Disappointment for Big Pharma
By
Sy Mukherjee
January 18, 2019
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents show
By
Sasha Rogelberg
Success
Less than 10 out of 250 billionaires have kept their promise to give away their fortune—and a philanthropy CEO says...
By
Orianna Rosa Royle
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartest
By
Nick Lichtenberg